QC
TWST icon

Quadrature Capital’s Twist Bioscience TWST Stock Holding History

Quadrature Capital’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.49M Buy
+33,930
New +$2.21M 0.03% 364
2026
Q1 		– Sell
-14,998
Closed -$476K – 1866
2025
Q4 		$476K Buy
+14,998
New +$468K ﹤0.01% 706

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Quadrature Capital's TWST Position: Q2 2026 in Review

Quadrature Capital opened a new position in Twist Bioscience (TWST) in Q2 2026: 33,930 shares worth $3.49M. The stake represents 0.03% of the portfolio and ranks #364 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in TWST as recently as Q4 2025.

Quadrature Capital first reported a position in TWST in Q4 2025 and has held it in 2 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Quadrature Capital held 33,930 shares of Twist Bioscience worth $3.49M as of Q2 2026.
  • Twist Bioscience was a new Quadrature Capital position in Q2 2026.
  • Twist Bioscience made up 0.03% of Quadrature Capital's portfolio in Q2 2026, its #364 holding.
  • Quadrature Capital first reported a position in Twist Bioscience in Q4 2025 and has held it in 2 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.